Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07806383) titled 'Effects of a Sugar-Based Synbiotic Product on Cardiometabolic and Intestinal Health (SUGAR-SYN BC3O)' on Sept. 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Federico II University
Condition:
Overweight Adults
Intervention:
Dietary Supplement: Sugar-Based Synbiotic Product
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: May 4, 2026
Target Sample Size: 20
Countries of Recruitment:
Italy
To know ...